Pipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15
May 13 2008 - 8:05AM
Marketwired
ANN ARBOR, MI , a specialty pharmaceutical company developing
innovative late-stage drug candidates for the treatment of
neurologic and autoimmune diseases, announced that it will release
its financial results for the first quarter of fiscal year 2008 on
Thursday, May 15th. The Company will host a teleconference call at
4:30 p.m. EDT that day to discuss the results; at that time Pipex
will also provide a review of the Company's clinical pipeline.
There will be a question-and-answer session directly following the
presentation of the results.
In order to participate in the conference call, please call toll
free: 800-355-4959 (US); international dial-in: 416-695-6622. An
audio recording of the call will be available for replay for a
period of at least 15 days after the call's completion at
http://www.pipexinc.com.
About Pipex Pharmaceuticals, Inc.
Pipex Pharmaceuticals, Inc. ("Pipex") is a specialty
pharmaceutical company that is developing four proprietary,
late-stage drug candidates for the treatment of neurologic and
fibrotic diseases. Pipex's strategy is to exclusively in-license
proprietary, clinical-stage drug candidates and to complete the
further clinical testing, manufacturing and regulatory requirements
sufficient to seek marketing authorizations via the filing of New
Drug Applications (NDAs). Pipex's drug candidates address the
following market opportunities, Multiple Sclerosis (MS), Dry
Age-Related Macular Degeneration (AMD), Fibromyalgia, Huntington's
Disease, Alzheimer's Disease, neurologic Wilson's disease and
Idiopathic Pulmonary Fibrosis. For further information please visit
www.pipexinc.com.
For Further Information, Contact: Steve H. Kanzer, CPA, Esq.
Chairman and Chief Executive Officer 734-332-7800 Thomas Redington
Investor Relations Redington Inc. 203-222-7399
www.redingtoninc.com
Meet Kevin Pricing Power... (AMEX:PP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Meet Kevin Pricing Power... (AMEX:PP)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Meet Kevin Pricing Power ETF (American Stock Exchange): 0 recent articles
More Pipex Pharmaceuticals, Inc. News Articles